gdc
Submit Your Story
Subscribe

Lung Cancer

Lung Cancer Stigma Can Cause Death
Issue IntroductionsLung Cancer
Lung Cancer Stigma Can Cause Death
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
November 2020 – Lung Cancer
Just Ask Frank Sierawski: Anybody with Lungs Can Get Lung Cancer
Lung CancerPatient Stories
Just Ask Frank Sierawski: Anybody with Lungs Can Get Lung Cancer
By Chase Doyle
November 2020 – Lung Cancer
Nutrition Tips for Patients with Lung Cancer: Maintaining a Healthy Body Weight
Lung CancerNutrition & Cancer
Nutrition Tips for Patients with Lung Cancer: Maintaining a Healthy Body Weight
By Julie LG Lanford, MPH, RD, CSO, LDN
November 2020 – Lung Cancer
Why I Fight for Lung Cancer Awareness
CaregiversLung Cancer
Why I Fight for Lung Cancer Awareness
By Danielle Hicks
November 2020 – Lung Cancer
Gavreto Second Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
FDA Approvals, News & UpdatesLung Cancer
Gavreto Second Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
November 2020 – Lung Cancer
Beauty Is a Side Effect of (Lung) Cancer
Lung CancerPatient Stories
Beauty Is a Side Effect of (Lung) Cancer
By A. J. Patel
November 2020 – Lung Cancer
New Therapies Improve Survival in Patients with Lung Cancer Associated with a Biomarker
BiomarkersLung Cancer
New Therapies Improve Survival in Patients with Lung Cancer Associated with a Biomarker
By Dana Taylor
November 2020 – Lung Cancer
Retevmo First Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
FDA Approvals, News & UpdatesLung Cancer
Retevmo First Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
November 2020 – Lung Cancer
Oncogene Alterations Affect the Response to Targeted Therapies in Patients with Non–Small-Cell Lung Cancer and ALK Rearrangements
Lung Cancer
Oncogene Alterations Affect the Response to Targeted Therapies in Patients with Non–Small-Cell Lung Cancer and ALK Rearrangements
By Chase Doyle
November 2020 – Lung Cancer
Early Adjuvant Treatment with Tagrisso Improves Outcomes in Patients with Non–Small-Cell Lung Cancer and EGFR Mutations
Lung Cancer
Early Adjuvant Treatment with Tagrisso Improves Outcomes in Patients with Non–Small-Cell Lung Cancer and EGFR Mutations
By Wayne Kuznar
ASCO 2020 Highlights
Treatment with the targeted drug Tagrisso (osimertinib) as an adjuvant therapy (used in addition to primary therapy, such as surgery or chemotherapy) significantly reduces disease recurrence in patients with localized non–small-cell lung cancer (NSCLC) and an EGFR gene mutation (alteration).
Page 1 of 9
Results 1 - 10 of 88

Subscribe to CONQUER™: the patient voice™ magazine

Receive timely cancer news & updates, patient stories, and more.

Country